SOLID ADVANCED TUMOR
Clinical trials for SOLID ADVANCED TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID ADVANCED TUMOR trials appear
Sign up with your email to follow new studies for SOLID ADVANCED TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on advanced cancers enters human testing
Disease control Recruiting nowThis study is testing a new combination of two drugs, MCLA-129 and ensartinib, for people with advanced solid tumors that have a specific genetic marker (MET). The main goals are to find a safe and effective dose and to see if the combination can shrink tumors or slow their growt…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New cancer drug trial seeks to boost immune system against tumors
Disease control Recruiting nowThis early-stage clinical trial is testing a new immunotherapy drug called OSE-279 in people with advanced solid tumors or lymphomas. The study has three parts: first finding the safest dose, then testing safety when combined with another drug for lung cancer, and finally measuri…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC